Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial

Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease

(2016) Steven J. Greenberg et al.   Therapeutic Advances in Neurological Disorders

H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes

(2016) Christen Kutz   Therapeutic Advances in Chronic Disease

Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy

(2016) Ralf A. Linker et al.   Therapeutic Advances in Chronic Disease

Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis

(2015) Aaron E. Miller   CLINICAL THERAPEUTICS

A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis

(2015) Emanuele D’Amico et al.   Expert Opinion On Drug Safety

Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort

(2015) Dalia L. Rotstein et al.   JAMA Neurology

Adrenocorticotropin hormone 1-39 promotes proliferation and differentiation of oligodendroglial progenitor cells and protects from excitotoxic and inflammation-related damage

(2014) Joyce A. Benjamins et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Evaluation of clinical parameters during and after treatment of attack in patients with clinically isolated syndrome: Comparison of the results with that of multiple sclerosis patients

(2013) Bilge Piri Cinar et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Short-Term Safety of Pulse Steroid Therapy in Multiple Sclerosis Relapses

(2013) Vahid Shaygannejad et al.   CLINICAL NEUROPHARMACOLOGY

Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis

(2013) Montserrat Moreno et al.   JOURNAL OF NEUROIMMUNOLOGY

Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment

(2013) Zsolt Mezei et al.   JOURNAL OF NEUROLOGY

Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis

(2012) B. G. Arnason et al.   Multiple Sclerosis Journal

Treatment of Acute Relapses in Multiple Sclerosis

(2012) Regina Berkovich   Neurotherapeutics

Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis

(2011) R Zivadinov et al.   Multiple Sclerosis Journal

The renaissance of corticotropin therapy in proteinuric nephropathies

(2011) Rujun Gong   Nature Reviews Nephrology

The Melanocortin System in Control of Inflammation

(2011) Anna Catania et al.   TheScientificWorldJOURNAL

Ingested (oral) ACTH inhibits EAE

(2010) Staley A. Brod et al.   JOURNAL OF NEUROIMMUNOLOGY

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

(2010) Mads Ravnborg et al.   LANCET NEUROLOGY

Corticosteroids in the treatment of multiple sclerosis

(2009) K. M. Myhr et al.   ACTA NEUROLOGICA SCANDINAVICA

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

(2009) Per Soelberg Sorensen et al.   LANCET NEUROLOGY

α-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effectsin Vitroandin Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases

(2008) Thomas Brzoska et al.   ENDOCRINE REVIEWS

Invited Article: Lost in a jungle of evidence: We need a compass

(2008) J. French et al.   NEUROLOGY

Neuroprotective actions of melanocortins: a therapeutic opportunity

(2008) Anna Catania   TRENDS IN NEUROSCIENCES

Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing–remitting multiple sclerosis

(2007) Robert Zivadinov et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES